Effects of megestrol acetate on growth and secretion of a pituitary tumor
- 1 August 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (8) , 925-931
- https://doi.org/10.1016/0014-2964(81)90316-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- The Inability of Bromocriptine to Inhibit Prolactin Secretion by Transplantable Rat Pituitary Tumors: Observations on the Mechanism and Dynamics of the Autofeedback Regulation of Prolactin Secretion*Endocrinology, 1979
- Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyCancer, 1978
- Further clinical studies with megestrol acetate in advanced breast cancerCancer, 1976
- A clinical trial of megestrol acetate in advanced breast cancerCancer, 1974
- Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal CancerBritish Journal of Cancer, 1971
- Progestogen treatment of recurrent endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1971
- On the Control of Prolactin and Growth Hormone Synthesis in Rat Pituitary Glands1Endocrinology, 1968
- ANTI-OVULATORY AND OTHER BIOLOGICAL PROPERTIES OF MEGESTROL ACETATE 17 ACETOXY-6 METHYL PREGNA 4:6-DIENE-3:20-DIONE (B.D.H. 1298)Reproduction, 1963
- PRODUCTION OF ADRENAL ATROPHY BY 6-METHYL-17-ACETOXYPROGESTERONE, WITH REMARKS ON THE ADRENAL EFFECTS OF OTHER PROGESTATIONAL AGENTSEndocrinology, 1959